SCHEMBL23768677

SCHEMBL23768677

CCOC(=O)[C@@H]1CNC[C@H]1C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.42
PKM P14618 1/20 0.42
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 1/20 0.37
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
PPM1B O75688 1/20 0.35
PTPN1 P18031 1/20 0.35
PPP1CC P36873 1/20 0.35
ALDH1A1 P00352 1/20 0.34
CHEK1 O14757 2/20 0.34
CHEK2 O96017 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23419884 1.00 MAPT (0.42) MAPTPKMNPC1RAB9ASMN1; SMN2
SCHEMBL28357350 1.00 MAPT (0.42) MAPTPKMNPC1RAB9ASMN1; SMN2
SCHEMBL12930960 0.88 MAPT (0.46) MAPTPKMCA12CA1CA2
SCHEMBL852591 0.88 MAPT (0.46) MAPTPKMCA12CA1CA2
SCHEMBL852590 0.88 MAPT (0.46) MAPTPKMCA12CA1CA2
SCHEMBL18308315 0.84 MAPT (0.56) MAPTPKMNPC1RAB9ASMN1; SMN2
SCHEMBL15202778 0.84 MAPT (0.52) MAPTPKMNPC1RAB9ASMN1; SMN2
SCHEMBL21866134 0.84 MAPT (0.56) MAPTPKMNPC1RAB9ASMN1; SMN2
SCHEMBL13406363 0.84 MAPT (0.56) MAPTPKMNPC1RAB9ASMN1; SMN2
SCHEMBL1933511 0.84 MAPT (0.52) MAPTPKMNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023242598-A1 BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2023-12-21 WO disclosed
EP-3630772-B1 METHODS OF MAKING AND USING PDE9 INHIBITORS IMARA INC (US) 2023-11-01 EP disclosed
EP-3865484-A1 PDE9 INHIBITOR WITH IMIDAZO PYRAZINONE BACKBONE FOR TREATMENT OF PERIPHERAL DISEASES H. Lundbeck A/S (DK) 2021-08-18 EP disclosed